Skip to main content

In the News - Forbes - Tessier-Lavigne

Genentech Brain Trust Leaves With $217 Million For New Startup To Fight Alzheimer's And Parkinson's   "Three former top researchers at Genentech, the legendary biotech that is now part of Roche Holding, have raised $217 million in venture capital to start a new company, Denali Therapeutics, focus...

Research shows how antibodies produce vaccine-like effect against tumors

The problem with traditional cancer treatments is that their effects don’t always last:  Stop the therapy and the disease may return. That’s why antibody therapy — which not only kills tumors, but also appears to train the body’s own defenses to recognize them — has such promise. New rese...

Fragments of tRNA suggest a novel mechanism for cancer progression

For years, scientists have been puzzled by the presence of short stretches of genetic material floating inside a variety of cells, ranging from bacteria to mammals, including humans. These fragments are pieces of the genetic instructions cells use to make proteins, but are too short a length to s...

Rockefeller scientists resolve long-standing debate over how many bacteria fight off invaders

Every inch of our body, inside and out, is oozing with bacteria. In fact, the human body carries 10 times the number of bacterial cells as human cells. Many are our friends, helping us digest food and fight off infections, for instance. But much about these abundant organisms, upon which our life...

Paul Nurse to receive Friesen International Prize

Paul Nurse, president emeritus at Rockefeller, has been awarded the Henry G. Friesen International Prize in Health Research. A Canadian prize, established by the Friends of Canadian Institutes of Health Research in collaboration with the Canadian Academy of Health Sciences, the prize honors excep...

Odd histone helps suppress jumping genes in stem cells, study says

A family of proteins known as histones provides support and structure to DNA, but for years, scientists have been puzzling over occasional outliers among these histones, which appear to exist for specific, but often mysterious reasons. Now, researchers have uncovered a new purpose for one such hi...

Leslie Vosshall and Jean-Laurent Casanova elected to the National Academy of Sciences

Two Rockefeller scientists have been elected to the National Academy of Sciences. Leslie B. Vosshall, Robin Chemers Neustein Professor and head of the Laboratory of Neurogenetics and Behavior, has been named a member, and Jean-Laurent Casanova, senior attending physician, professor, and head of t...

Elaine Fuchs wins cell biologists’ highest honor

In recognition of her pioneering research on mammalian skin and adult stem cells, Elaine Fuchs, the Rebecca C. Lancefield Professor at The Rockefeller University, has received the E.B. Wilson Medal, the highest scientific honor bestowed by the American Society for Cell Biology. The medal will be ...

Charles Rice to receive 2015 Robert Koch Award

Charles M. Rice, Maurice R. and Corinne P. Greenberg Professor in Virology, has been selected to receive the 2015 Robert Koch Award. Rice will share the €100,000 prize, awarded by the Robert Koch Foundation of Germany, with Ralf Bartenschlager from Heidelberg University for their groundbreaking w...

Research on the genetic roots of a blood disorder illustrates the challenges in parsing genetic data

Accumulating data, even genetic data, is easy. Understanding the meaning of those data can be more of a challenge. As genetic testing becomes increasingly popular, more and more patients and physicians are faced with tough questions: Does a particular genetic variation translate into a predisposi...